FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

371723008: Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197023014 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1210334010 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4722981000005116 sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg Is a Metronidazole-containing product in oral dose form false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg Is a Product containing tetracycline in oral dose form (medicinal product form) false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole (substance) false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracycline (substance) false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg Is a Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth subsalicylate false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antacid (substance) false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg Has manufactured dose form Oral dose form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start